FIGURE 2.
Best percent change in sum of target lesion diameters from baseline per independent review committee in efficacy‐evaluable patients with programmed death ligand 1‐positive urothelial carcinoma
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.